X4 Pharmaceuticals is a BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending ...

Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic ...

Boston's innovation ego just got some fresh receipts. Five Boston-area companies landed coveted spots on this year's ...

Information on The List was supplied by individual companies through questionnaires and could not be independently verified by the Puget Sound Business Journal. Only those that responded to our ...

Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.

Induced pluripotent stem cell technology is a promising, rapidly evolving field with the potential to transform cell-based therapeutics across a range of disease areas that have significant unmet ...